EUVIMEDEUVIMED entdecken
Crossref

Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer

Danjun Wu iD, Yaning Ji, Weili Ji, Hong Tian, Yiwei Dai, Yifei Chen, Gongmin Shen, Gensheng Yang iD

Biomacromolecules · 2025

DOI: 10.1021/acs.biomac.5c00186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2025. Verfasst von Danjun Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. Hauptthemen laut MEDLINE: Doxorubicin, Micelles, Photothermal Therapy, Tumor Hypoxia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanomedicines with a size of approximately 200 nm preferentially accumulate at the tumor peripheries but exhibit limited penetration into deeper hypoxic regions. To overcome this, we engineered near-infrared (NIR) light-triggered, size-tunable nanomicelles (Au@PtNRs/DOX-M) to enhance tumor accumulation and penetration, while alleviating hypoxia. Dumbbell-shaped platinum-deposited gold nanorods (Au@PtNRs), with a high photothermal conversion efficiency (68.44%), were integrated into thermoresponsive, doxorubicin (DOX)-loaded nanomicelles. Upon NIR irradiation, Au@PtNRs induced light-to-heat conversion, disassembling micelles into ultrasmall micelles for enhanced tumor penetration and on-demand DOX release. Concurrently, Pt nanoparticles catalyzed the decomposition of reactive oxygen species (ROS) to mitigate ROS-induced damage to adjacent healthy cells, and scavenged the elevated H 2 O 2 within tumors, generating abundant oxygen to reoxygenate the hypoxic microenvironment. This study establishes an efficient, size-tunable nanomicelle platform for enhancing hypoxia-impeded deep penetration of nanomedicines and offers a promising strategy for synergistic chemo-photothermal therapy, achieving tumor inhibition rates of up to 99% in MCF-7 tumor-bearing mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinMicellesPhotothermal TherapyTumor HypoxiaNeoplasmsMetal NanoparticlesAnimalsMiceHumansGoldReactive Oxygen SpeciesMice, Inbred BALB CFemaleMice, NudeCell Line, TumorPlatinumNanotubes

Substanzen

DoxorubicinMicellesGoldReactive Oxygen SpeciesPlatinum

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
  • Hangzhou Guoguang Pharmaceutical Co, Ltd, Hangzhou 310018, China.

ORCID-Profile: Danjun Wu, Gensheng Yang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Wu, D., Ji, Y., Ji, W., Tian, H., Dai, Y., Chen, Y., Shen, G., & Yang, G. (2025). Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer. Biomacromolecules. https://doi.org/10.1021/acs.biomac.5c00186

Vancouver

Wu D, Ji Y, Ji W, Tian H, Dai Y, Chen Y, et al. Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer. Biomacromolecules. 2025. doi:10.1021/acs.biomac.5c00186

BibTeX
@article{Wu2025,
  author = {Wu, Danjun and Ji, Yaning and Ji, Weili and Tian, Hong and Dai, Yiwei and Chen, Yifei and Shen, Gongmin and Yang, Gensheng},
  title = {Thermoresponsive, Size-Tunable Hybrid Nanomicelles to Alleviate Tumor Hypoxia and Enhance Chemo-Photothermal Synergy Therapy of Cancer},
  journal = {Biomacromolecules},
  year = {2025},
  doi = {10.1021/acs.biomac.5c00186}
}
Kostenlos starten →